Literature DB >> 18065445

Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.

Sai Kuchibhotla1, Difernando Vanegas, David J Kennedy, Ella Guy, George Nimako, Richard E Morton, Maria Febbraio.   

Abstract

AIMS: The role of scavenger receptors in atherogenesis is controversial as a result of conflicting reports and a recent hypothesis suggesting that scavenger receptor absence would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis lesion development in the apolipoprotein E knock-out (apoE degrees ) model.
METHODS: We created background-related strains of apoE degrees , scavenger receptor A I/II knock-out (SRA degrees )/apoE degrees , CD36 knock-out (CD36 degrees )/apoE degrees , and CD36 degrees /SRA degrees /apoE degrees mice that were >99% C57Bl/6. Four-week-old mice were fed a Western diet for 12 weeks and were assessed for lesion burden/morphology, risk factors for atherosclerosis, inflammatory mediators, and macrophage function.
RESULTS: There was a 61 and 74% decrease in total aortic lesion area in CD36 degrees /apoE degrees males and females, respectively, compared with apoE degrees controls. The absence of SRA was protective (32% decrease in lesion) in female mice. The combined absence of CD36 and SRA provided no further protection in either gender. Macrophages from mice lacking CD36 had decreased pro-inflammatory characteristics and less migration to a pro-inflammatory stimulus. Plasma levels of cytokines/chemokines showed that CD36 degrees /apoE degrees and CD36 degrees /SRA degrees /apoE degrees mice had a less pro-inflammatory phenotype compared with apoE degrees and SRA degrees /apoE degrees mice. Oblivious mice in the apoE degrees background ruled out potential 'passenger gene' effects in the case of CD36.
CONCLUSION: These results provide new insights into the pro-atherogenic mechanisms of CD36 by implicating processes other than modified lipoprotein uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065445      PMCID: PMC2810680          DOI: 10.1093/cvr/cvm093

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

1.  A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples.

Authors:  D W Garber; K R Kulkarni; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

4.  Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors:  Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

5.  A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

Authors:  Kathryn J Moore; Joseph El Khoury; Lea A Medeiros; Kinya Terada; Changiz Geula; Andrew D Luster; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-09-17       Impact factor: 5.157

6.  Polymorphism of class A scavenger receptors in C57BL/6 mice.

Authors:  A Daugherty; S C Whitman; A E Block; D L Rateri
Journal:  J Lipid Res       Date:  2000-10       Impact factor: 5.922

7.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

Authors:  A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

8.  LDL and HDL enriched in triglyceride promote abnormal cholesterol transport.

Authors:  Josephine W Skeggs; Richard E Morton
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

9.  A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes.

Authors:  Frédéric Leprêtre; Francis Vasseur; Martine Vaxillaire; Philipp E Scherer; Saira Ali; Kenneth Linton; Timothy Aitman; Philippe Froguel
Journal:  Hum Mutat       Date:  2004-07       Impact factor: 4.878

10.  CD36 mediates the innate host response to beta-amyloid.

Authors:  Joseph B El Khoury; Kathryn J Moore; Terry K Means; Josephine Leung; Kinya Terada; Michelle Toft; Mason W Freeman; Andrew D Luster
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more
  80 in total

1.  Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation.

Authors:  S Ohidar Rahaman; Wojciech Swat; Maria Febbraio; Roy L Silverstein
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 2.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

3.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

4.  COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.

Authors:  Kamran Anwar; Iryna Voloshyna; Michael J Littlefield; Steven E Carsons; Peter A Wirkowski; Nadia L Jaber; Andrew Sohn; Sajan Eapen; Allison B Reiss
Journal:  Lipids       Date:  2010-12-22       Impact factor: 1.880

Review 5.  How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.

Authors:  Jillian P Rhoads; Amy S Major
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 6.  The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  J Lipid Res       Date:  2008-12-11       Impact factor: 5.922

Review 7.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

Review 8.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

9.  Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.

Authors:  Allison B Reiss; David W Wan; Kamran Anwar; Joan T Merrill; Peter A Wirkowski; Nidhi Shah; Bruce N Cronstein; Edwin S L Chan; Steven E Carsons
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

10.  Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.

Authors:  David J Kennedy; Sai D Kuchibhotla; Ella Guy; Young Mi Park; George Nimako; DiFernando Vanegas; Richard E Morton; Maria Febbraio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.